To hear audio pronunciation of this topic, purchase a subscription or log in.
- Bynfezia Pen
- SandoSTATIN LAR
- SandoSTATIN LAR Depot
There's more to see -- the rest of this topic is available only to subscribers.
Vallerand, April Hazard., et al. "Octreotide." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51554/all/octreotide.
Vallerand AHA, Sanoski CAC, Quiring CC. Octreotide. Davis's Drug Guide. F.A. Davis Company; 2023. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51554/all/octreotide. Accessed June 5, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Octreotide. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51554/all/octreotide
Vallerand AHA, Sanoski CAC, Quiring CC. Octreotide [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 June 05]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51554/all/octreotide.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - octreotide ID - 51554 A1 - Sanoski,Cynthia A, AU - Vallerand,April Hazard, AU - Quiring,Courtney, BT - Davis's Drug Guide UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51554/all/octreotide PB - F.A. Davis Company ET - 18 DB - Medicine Central DP - Unbound Medicine ER -